Obligation to Issue Warrants. On the Warrant Closing Date (as defined below), PublicCo shall issue to each Buyer for no additional consideration, Series A Warrants, Series B Warrants and Series C Warrants each to acquire (x) an initial amount of ADSs equal to 4,276,252 (subject to further adjustments as set forth therein)one hundred percent (100%) of the quotient determined by dividing the Purchase Price paid by such Buyer on the Shares Closing Date, by the lower of the Closing Per Share Price and the Initial Per Share Price, and (y) in the case of the Series C Warrants, (A) an initial amount of ADSs equal to one hundred percent (100%) of the quotient determined by dividing each Buyer's Series C Warrants' dollar amount set forth opposite such Buyer's name in column (3) on the Schedule of Buyers, by the lower of the Closing Per Share Price and the Initial Per Share Price 2,389,670 (subject to further adjustments as set forth therein) and (B) Series A Warrants and Series B Warrants, each to purchase a number ADSs determined pursuant to the terms thereof (the "Warrant Closing" and together with the Shares Closing, the "Closings" and each a "Closing")."
Obligation to Issue Warrants. On the Warrant Closing Date (as defined below), and for no additional consideration, Rexahn shall issue to each Buyer (x) Series A Warrants to acquire an initial amount of shares of Rexahn Common Stock equal to one-hundred (100%) percent of the quotient determined by dividing the Purchase Price paid by such Buyer on the Closing Date, by the Final Per Share Price and (y) Series B Warrants to acquire Series B Warrant Shares in accordance with its terms and conditions (the “Warrant Closing”).
Obligation to Issue Warrants. On the Warrant Closing Date (as defined below), PublicCo shall issue to each Buyer for no additional consideration, (x) Series A-1 Warrants to purchase a number of shares of PublicCo Common Stock equal to 500% of the Initial Purchased Shares and Series A-2 Warrants to purchase a number of shares of PublicCo Common Stock equal to 450% of the Initial Purchased Shares, respectively, and (y) Series T Warrants to acquire (A) a number of shares of PublicCo Common Stock equal to 320.856% of the Initial Purchased Shares and (B) Series A-1 Warrants and Series A-2 Warrants, each to purchase a number of shares of PublicCo Common Stock equal to 320.856% of the Initial Purchased Shares pursuant to the terms thereof (the "Warrant Closing" and together with the Shares Closing, the "Closings" and each a "Closing").
Obligation to Issue Warrants. On the Warrant Closing Date (as defined below), and for no additional consideration, Apricus shall issue to each Buyer (x) Series A Warrants to acquire up to eighty (80%) percent of that number of shares of Apricus Common Stock such Buyer has received or is entitled to receive in exchange for the Common Shares pursuant to this Agreement without giving effect to the limitations of Section 1(c)(iv) and (y) Series B Warrants to acquire the Series B Warrant Shares in accordance with its terms and conditions (the "Warrant Closing"). Exhibit 10.1
Obligation to Issue Warrants. On the Warrant Closing Date (as defined below), and for no additional consideration, Seneca shall issue to each Buyer Warrants to acquire an initial amount of shares of Seneca Common Stock equal to one hundred percent (100%) of the quotient determined by dividing the Purchase Price paid by such Buyer on the Closing Date, by the lower of the Closing Per Share Price and the Initial Per Share Price (the "Warrant Closing").
Obligation to Issue Warrants. On the Warrant Closing Date (as defined below), and for no additional consideration, BioPharmX shall issue to each Buyer (x) Series A Warrants to acquire an initial amount of shares of BioPharmX Common Stock equal to seventy-five (75%) percent of the quotient determined by dividing the Purchase Price paid by such Buyer on the Closing Date, by the Final Per Share Price and (y) Series B Warrants to acquire Series B Warrant Shares in accordance with its terms and conditions (the “Warrant Closing”).
Obligation to Issue Warrants. Subject to the terms and conditions of this Agreement, MAXF shall issue to the Bankers and other employees of the Group up to a total of one million (1,000,000) common stock purchase warrants (the "WARRANTS"), each exercisable for one share of the common stock of MAXF, par value $.001 per share (the "COMMON STOCK"). Concurrent with the execution and delivery of this Agreement by MAXF, on the one hand, and the Bankers, on the other hand (the "FIRST CLOSING"), MAXF shall make available to the Bankers an aggregate of five hundred thousand (500,000) of the Warrants (the "INITIAL WARRANTS"). At the Second Closing (as defined below), MAXF shall make available to the Bankers an aggregate of an additional two hundred fifty thousand (250,000) Warrants (the "SECONDARY WARRANTS"). At the Third Closing (as defined below), MAXF shall make available to the Bankers an aggregate of an additional two hundred fifty thousand (250,000) Warrants (the "FINAL WARRANTS"). All Warrants shall, at the relevant Closing or thereafter, be allocated and granted by the Bankers, and issued by MAXF, to employees of the Group (including themselves) (collectively, "EMPLOYEES") as and when the Bankers may from time to time recommend and specify in writing to MAXF; provided, however, that all such recommended grants and related issuances shall be subject to the prior approval of the senior management of MAXF, which shall not be unreasonably withheld or delayed.
Obligation to Issue Warrants. Each Seller hereby covenants that it shall fully perform its obligations under the Assumed Contracts that pertain to the issuance of warrants to purchase shares of ProElite capital stock, which obligation to issue warrants shall not be assumed by Buyer.
Obligation to Issue Warrants. On the Warrant Closing Date (as defined below), and for no additional consideration, Chanticleer shall issue to each Buyer (x) Series A Warrants to acquire an initial amount of shares of Chanticleer Common Stock equal to seventy-five (75%) percent of the quotient determined by dividing the Purchase Price paid by such Buyer on the Closing Date, by the Final Per Share Price and (y) Series B Warrants to acquire Series B Warrant Shares in accordance with its terms and conditions (the “Warrant Closing”).
Obligation to Issue Warrants. On the Warrant Closing Date (as defined below), and for no additional consideration, Histogenics shall issue to each Buyer (x) Series A Warrants to acquire up to two hundred (200%) percent of that number of shares of Histogenics Common Stock such Buyer has received or is entitled to receive in exchange for the Common Shares pursuant to this Agreement without giving effect to the limitations of Section 1(c)(iv), (y) Series B Warrants to acquire the Series B Warrant Shares in accordance with its terms and conditions and (z) Series C Warrants to acquire the Series C Warrant Shares in accordance with its terms and conditions (the “Warrant Closing”).
